Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

Results of a groundbreaking, randomized trial involving more than 105,000 women reveals that the use of artificial ...

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

The FDA says new labels will make it easier to spot harmful ingredients. A UVA nutritionist suggests taking a holistic ...

Silver Spring’s United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to be transplanted into humans. It's as significant for the ...

Brainomix, an award-winning pioneer of state-of-the-art artificial intelligence (AI) imaging solutions, will be unveiling a ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...

EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...

United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has ...

The East West Shrine Bowl in Arlington has a recognizable logo showing a football player and a little girl that goes back ...

Christophe Gardella, Ph.D., chief technical officer for BrightHeart, the Paris-based manufacturer of the AI-based software BrightHeart received FDA 510(k) clearance for its first AI software product ...